Michigan State University Center for Bleeding Disorders & Clotting Disorders

East Lansing, Michigan 49805

1 studies enrolling now · 4 studies all time

What they study most

Factor VII Deficiency, Glanzmann Thrombasthenia, Hemophilia A, Hemophilia A With Inhibitor, Von Willebrand Disease (VWD)

Studies at this site

• A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD) — Recruiting now
• Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry — Stopped early
• Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders — Stopped early
• Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A — Status unconfirmed